Immutep share price today

(IMMP)

Immutep share price is $1.95 & ₹166.14 as on 25 Dec 2024, 2.30 'hrs' IST

$1.95

▲

-0.03

(-1.52%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Immutep share price in Dollar and Rupees. Guide to invest in Immutep from India. Also see the sentimental analysis on Indian investors investing in Immutep. Get details on the Indian mutual funds that are investing in Immutep. Get Analyst recommendations and forecasts along with all the Immutep's financials.

Immutep share price movements

Today's Low: $1.95
Today's High: $2.05
$1.95
0.0%
Downside
Day's Volatility :4.88%
Upside
4.88%
52 Weeks Low: $1.66
52 Weeks High: $3.34
$1.95
14.87%
Downside
52 Weeks Volatility :50.22%
Upside
41.53%

Immutep Returns

Period	Immutep Ltd	Sector (Health Care)	Index (Russel 2000)
3 Months	-14.1%	-9.0%	0.0%
6 Months	4.28%	-4.6%	0.0%
1 Year	-20.73%	3.0%	0.0%
3 Years	-42.82%	0.0%	-21.1%

Immutep Key Statistics

in dollars & INR

Previous Close	$1.98
Open	$1.98
Today's High	$2.05
Today's Low	$1.95
Market Capitalization	$304.2M
Today's Volume	$103.9K
52 Week High	$3.335
52 Week Low	$1.66
Revenue TTM	$3.8M
EBITDA	$-44.5M
Earnings Per Share (EPS)	$-0.23
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-26.21%

How to invest in Immutep from India?

It is very easy for Indian residents to invest directly in Immutep from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immutep stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immutep or IMMP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immutep or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immutep shares which would translate to 0.437 fractional shares of Immutep as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immutep, in just a few clicks!

Returns in Immutep for Indian investors in Rupees

Investment Value

₹1,00,000

Immutep investment value today

Current value as on today

₹81,507

Returns

₹18,493

(-18.49%)

Returns from Immutep Stock

₹20,732 (-20.73%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Immutep

67%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Immutep on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 67% more investors are searching Immutep in the last 30 days versus the previous period.

Global Institutional Holdings in Immutep

BlackRock Inc
0.58%
Meridian Wealth Management, LLC
0.27%
Jane Street Group LLC
0.09%
Susquehanna International Group, LLP
0.08%
XY Capital Ltd
0.07%
PFG Investments, LLC
0.04%

Analyst Recommendation on Immutep

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Immutep(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Immutep

What analysts predicted

Upside of 387.18%

Current:

$1.95

Target:

$9.50

Insights on Immutep

Price Movement
In the last 7 days, IMMP stock has moved down by -8.0%
Decreasing Revenue
Revenue is down for the last 3 quarters, 2.11M → 1.73M (in $), with an average decrease of 9.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -19.27M → -21.48M (in $), with an average decrease of 3.8% per quarter
IMMP vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 44.2%
IMMP vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 68.8%
Price to Sales
ForIMMP every $1 of sales, investors are willing to pay $65.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Immutep Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$97.1K	↓ 94.69%
Net Income	$-11.3M	↑ 27.65%
Net Profit Margin	-11.6K%	↓ 11155.46%

	FY20	Y/Y Change
Revenue	$5.2M	↑ 5255.8%
Net Income	$-9.3M	↓ 17.22%
Net Profit Margin	-179.9%	↑ 11460.11%

	FY21	Y/Y Change
Revenue	$3.0M	↓ 47.0%
Net Income	$-22.8M	↑ 122.02%
Net Profit Margin	-753.57%	↓ 573.67%

	FY22	Y/Y Change
Revenue	$119.8K	↓ 95.71%
Net Income	$-22.6M	↑ 7.72%
Net Profit Margin	-18.9K%	↓ 18152.94%

	FY23	Y/Y Change
Revenue	$2.4M	↑ 1957.72%
Net Income	$-26.8M	↑ 23.86%
Net Profit Margin	-1.1K%	↑ 17768.47%

	FY24	Y/Y Change
Revenue	$3.8M	↑ 9.59%
Net Income	$-42.7M	↑ 7.07%
Net Profit Margin	-1.1K%	↑ 26.17%

	Q3 FY23	Q/Q Change
Revenue	$1.8M	-
Net Income	$-19.3M	-
Net Profit Margin	-1.1K%	-

	Q4 FY23	Q/Q Change
Revenue	$2.1M	↑ 15.96%
Net Income	$-21.2M	↑ 10.14%
Net Profit Margin	-1.0K%	↑ 53.13%

	Q2 FY24	Q/Q Change
Revenue	$1.7M	↓ 17.98%
Net Income	$-21.5M	↑ 1.23%
Net Profit Margin	-1.2K%	↓ 235.57%

	Q3 FY24	Q/Q Change
Revenue	$1.7M	↑ 0.0%
Net Income	$-21.5M	↑ 0.0%
Net Profit Margin	-1.2K%	↑ 0.0%

	FY19	Y/Y Change
Profit	$-11.4M	↑ 123.54%

	FY20	Y/Y Change
Profit	$-10.3M	↓ 8.91%

	FY21	Y/Y Change
Profit	$1.4M	↓ 112.67%

	FY22	Y/Y Change
Profit	$-1.3M	↓ 199.74%

	FY23	Y/Y Change
Profit	$970.0K	↓ 176.27%

	FY24	Y/Y Change
Profit	$-37.7M	↓ 2711.31%

	Q3 FY23	Q/Q Change
Profit	$896.2K	-

	Q4 FY23	Q/Q Change
Profit	$1.1M	↑ 24.41%

	Q2 FY24	Q/Q Change
Profit	$-19.4M	↓ 1838.11%

	Q3 FY24	Q/Q Change
Profit	$-19.4M	↑ 0.0%

	FY19	Y/Y Change
Operating Cash Flow	$-10.6M	↑ 96.57%
Investing Cash Flow	$-28.8K	↑ 248.39%
Financing Cash Flow	$5.6M	↓ 56.46%

	FY20	Y/Y Change
Operating Cash Flow	$-7.5M	↓ 29.09%
Investing Cash Flow	$-13.3K	↓ 53.3%
Financing Cash Flow	$14.1M	↑ 155.57%

	FY21	Y/Y Change
Operating Cash Flow	$-13.5M	↑ 62.74%
Investing Cash Flow	$-11.9K	↓ 19.37%
Financing Cash Flow	$40.2M	↑ 157.25%

	FY22	Y/Y Change
Operating Cash Flow	$-21.3M	↑ 71.37%
Investing Cash Flow	$-16.1K	↑ 46.88%
Financing Cash Flow	$35.4M	↓ 4.47%

	FY23	Y/Y Change
Operating Cash Flow	$-24.1M	↑ 18.7%
Investing Cash Flow	$-55.6K	↑ 261.07%
Financing Cash Flow	$51.1M	↑ 51.1%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.6M	↓ 41.08%
Investing Cash Flow	$-7.9K	↑ 0.0%
Financing Cash Flow	$51.2M	↓ 165734.78%

Immutep Technicals Summary

Sell

Neutral

Buy

Immutep is currently in a neutral trading position according to technical analysis indicators.

Immutep Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Immutep Ltd	2.09%	4.28%	-20.73%	-42.82%	12.11%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Immutep Ltd	NA	NA	NA	0.0	-0.26	-0.17	NA	0.13
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Immutep Ltd	Buy	$304.2M	12.11%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Immutep

immutep is a globally active biotechnology company, listed on the australian stock exchange and on the nasdaq global market in the us. as a leader in personalized bio-therapeutic products for cancer, immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. immutep's main pipeline of products is based on the lag-3 immune control mechanism which plays a vital role in the regulation of the t cell immune response. the most clinically advanced product is a t cell immunostimulatory factor (apc activator), imp321, for cancer chemoimmunotherapy which has completed early phase ii trials. a number of additional lag-3 products including antibodies for immune response modulation in autoimmunity and cancer are being developed by large pharmaceutical partners.

Organization	Immutep
Employees	0
CEO	Mr. Marc Voigt
Industry	Health Technology

Management People of Immutep

Name	Title
Mr. Marc Voigt	CEO, MD, CFO, Chief Business Officer & Executive Director
Ms. Deanne Miller LLB	COO, General Counsel & Joint Company Secretary
Dr. Frederic Triebel M.D., Ph.D.	Chief Scientific Officer & Executive Director
Dr. Florian D. Vogl M.D., M.Sc., Ph.D.	Chief Medical Officer
Mr. Christian Mueller BBA, MSc.	Senior Vice President of Regulatory & Strategy
Ms. Indira Naidu	Joint Company Secretary

Important FAQs about investing in Immutep from India :

What is Immutep share price today?

Immutep share price today stands at $1.95, Open: $1.98 ; Previous Close: $1.98 ; High: $2.05 ; Low: $1.95 ; 52 Week High: $3.34 ; 52 Week Low: $1.66. The stock opens at $1.98, after a previous close of $1.98. The stock reached a daily high of $2.05 and a low of $1.95, with a 52-week high of $3.34 and a 52-week low of $1.66.

Can Indians buy Immutep shares?

Yes, Indians can invest in the Immutep (IMMP) from India.

With INDmoney, you can buy Immutep at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Immutep at zero transaction cost.

How can I buy Immutep shares from India?

It is very easy to buy Immutep from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immutep be purchased?

Yes, you can buy fractional shares of Immutep with INDmoney app.

What are the documents required to start investing in Immutep stocks?

To start investing in Immutep, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.